See more : ILJIN Holdings Co., Ltd. (015860.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Sonova Holding AG (SONVY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sonova Holding AG, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- PPB Group Berhad (4065.KL) Income Statement Analysis – Financial Results
- Education Management Corporation (EDMCQ) Income Statement Analysis – Financial Results
- Green River Gold Corp. (CCRRF) Income Statement Analysis – Financial Results
- Union Insurance Co., Ltd. (2816.TW) Income Statement Analysis – Financial Results
- KEIWA Incorporated (4251.T) Income Statement Analysis – Financial Results
Sonova Holding AG (SONVY)
About Sonova Holding AG
Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.63B | 3.74B | 3.36B | 2.60B | 2.92B | 2.76B | 2.65B | 2.40B | 2.07B | 2.04B | 1.95B | 1.80B | 1.62B | 1.62B | 1.50B | 1.25B | 1.20B | 1.07B | 866.68M | 660.38M | 637.60M | 550.54M | 576.08M |
| Cost of Revenue | 1.01B | 1.15B | 943.20M | 764.20M | 877.70M | 843.40M | 827.22M | 783.22M | 723.66M | 647.56M | 610.86M | 555.48M | 513.92M | 498.02M | 441.71M | 381.98M | 363.20M | 340.72M | 289.10M | 242.56M | 269.94M | 271.44M | 280.25M |
| Gross Profit | 2.62B | 2.59B | 2.42B | 1.84B | 2.04B | 1.92B | 1.82B | 1.61B | 1.35B | 1.39B | 1.34B | 1.24B | 1.11B | 1.12B | 1.06B | 867.22M | 841.58M | 732.08M | 577.59M | 417.81M | 367.67M | 279.11M | 295.83M |
| Gross Profit Ratio | 72.28% | 69.28% | 71.96% | 70.63% | 69.91% | 69.48% | 68.74% | 67.31% | 65.07% | 68.18% | 68.69% | 69.06% | 68.27% | 69.20% | 70.56% | 69.42% | 69.85% | 68.24% | 66.64% | 63.27% | 57.66% | 50.70% | 51.35% |
| Research & Development | 261.00M | 242.80M | 229.30M | 203.20M | 166.10M | 148.40M | 142.90M | 132.03M | 125.86M | 130.90M | 125.66M | 113.88M | 116.18M | 107.76M | 87.03M | 77.38M | 76.45M | 67.59M | 62.78M | 48.93M | 58.20M | 48.88M | 31.45M |
| General & Administrative | 340.90M | 330.20M | 320.90M | 250.90M | 309.00M | 269.30M | 265.50M | 242.89M | 194.22M | 201.04M | 195.23M | 181.52M | 168.67M | 185.19M | 141.97M | 117.72M | 115.00M | 108.10M | -112.74M | -73.35M | 78.22M | 60.87M | 70.10M |
| Selling & Marketing | 1.33B | 1.32B | 1.10B | 881.20M | 1.03B | 1.02B | 934.50M | 815.02M | 638.24M | 613.22M | 589.63M | 559.08M | 503.35M | 498.59M | 402.63M | 340.31M | 309.20M | 278.98M | 205.73M | 159.12M | 126.14M | 116.24M | 124.41M |
| SG&A | 1.68B | 1.59B | 1.41B | 1.08B | 1.34B | 1.24B | 1.20B | 1.01B | 807.67M | 814.26M | 784.85M | 740.59M | 672.02M | 683.78M | 544.59M | 458.03M | 424.20M | 387.08M | 92.99M | 85.77M | 204.36M | 177.12M | 194.51M |
| Other Expenses | 14.70M | 0.00 | 0.00 | 0.00 | -23.40M | 4.10M | -1.80M | -1.26M | -18.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.28M | 268.00K | -304.00K | -280.00K | 0.00 | 0.00 |
| Operating Expenses | 1.95B | 1.83B | 1.64B | 1.28B | 1.53B | 1.38B | 1.34B | 1.15B | 951.54M | 958.45M | 936.42M | 1.08B | 810.82M | 812.37M | 650.62M | 542.20M | 514.84M | 6.23M | 356.17M | 297.98M | 272.95M | 316.47M | 236.06M |
| Cost & Expenses | 2.96B | 2.98B | 2.58B | 2.04B | 2.41B | 2.23B | 2.17B | 1.93B | 1.68B | 1.61B | 1.55B | 1.64B | 1.32B | 1.31B | 1.09B | 924.18M | 878.04M | 346.96M | 645.26M | 540.54M | 542.89M | 587.90M | 516.31M |
| Interest Income | 1.20M | 1.50M | 1.40M | 1.80M | 2.50M | 1.60M | 1.62M | 3.80M | 2.01M | 1.07M | 2.13M | 2.61M | 4.42M | 0.00 | 5.05M | 8.17M | 11.33M | 9.04M | 4.37M | 1.19M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 28.20M | 23.10M | 34.50M | 24.00M | 8.80M | 5.10M | 9.36M | 13.60M | 12.25M | 2.95M | 7.64M | 5.92M | 5.98M | 0.00 | 9.10M | 8.35M | 33.13M | 3.46M | 1.01M | 3.18M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 246.20M | 239.70M | 211.10M | 196.10M | 200.10M | 127.60M | 134.76M | 111.84M | 88.74M | 84.95M | 83.10M | 81.66M | 78.31M | 102.85M | 208.17M | 40.75M | 35.25M | 32.15M | 27.00M | 25.31M | 32.27K | 874.69K | 32.05K |
| EBITDA | 921.70M | 978.70M | 960.90M | 755.30M | 711.00M | 659.60M | 615.50M | 566.46M | 487.28M | 508.23M | 485.32M | 236.04M | 366.07M | 409.16M | 616.15M | 371.86M | 371.68M | 319.82M | 244.85M | 153.61M | 94.75M | -36.48M | 59.80M |
| EBITDA Ratio | 25.41% | 26.79% | 29.61% | 29.03% | 24.38% | 24.03% | 23.03% | 24.05% | 23.43% | 24.97% | 24.87% | 13.15% | 23.06% | 27.50% | 51.50% | 29.77% | 30.85% | 29.81% | 28.12% | 23.38% | 14.86% | -6.63% | 10.38% |
| Operating Income | 669.90M | 761.80M | 785.10M | 559.20M | 510.90M | 536.40M | 474.49M | 464.25M | 396.74M | 429.07M | 404.03M | 155.56M | 287.70M | 270.81M | 406.75M | 325.01M | 326.74M | 287.67M | 212.70M | 125.80M | 94.71M | -37.36M | 59.77M |
| Operating Income Ratio | 18.47% | 20.38% | 23.34% | 21.49% | 17.52% | 19.41% | 17.93% | 19.38% | 19.15% | 21.08% | 20.71% | 8.66% | 17.76% | 16.75% | 27.11% | 26.02% | 27.12% | 26.81% | 24.54% | 19.05% | 14.85% | -6.79% | 10.38% |
| Total Other Income/Expenses | -22.60M | -31.10M | -31.80M | -19.00M | -7.60M | -6.60M | -7.26M | -6.35M | -6.38M | -8.75M | -9.45M | -211.21M | -5.92M | -10.70M | -160.30M | -2.26M | -23.44M | -441.64M | 4.13M | -673.00K | -975.00K | -4.48M | -6.62M |
| Income Before Tax | 647.30M | 711.70M | 725.20M | 598.50M | 500.00M | 527.50M | 475.74M | 417.47M | 395.49M | 420.32M | 394.58M | 148.46M | 281.78M | 260.11M | 246.46M | 322.76M | 303.30M | 284.21M | 216.83M | 125.12M | 93.74M | -41.84M | 53.15M |
| Income Before Tax Ratio | 17.85% | 19.04% | 21.56% | 23.00% | 17.14% | 19.09% | 17.98% | 17.43% | 19.09% | 20.65% | 20.22% | 8.27% | 17.40% | 16.09% | 16.43% | 25.84% | 25.17% | 26.49% | 25.02% | 18.95% | 14.70% | -7.60% | 9.23% |
| Income Tax Expense | 37.80M | 57.30M | 64.60M | 15.10M | 12.90M | 69.40M | 71.51M | 61.15M | 51.21M | 52.00M | 47.20M | 37.59M | 35.37M | 29.03M | 29.83M | 38.65M | 29.16M | 41.33M | 43.33M | 29.27M | 24.38M | 4.95M | 10.41M |
| Net Income | 601.00M | 647.50M | 649.00M | 581.00M | 483.20M | 454.10M | 400.10M | 349.17M | 337.03M | 359.99M | 340.83M | 109.75M | 246.76M | 231.01M | 217.22M | 284.82M | 273.35M | 241.63M | 172.47M | 95.02M | 68.88M | -46.88M | 42.63M |
| Net Income Ratio | 16.57% | 17.32% | 19.29% | 22.33% | 16.57% | 16.43% | 15.12% | 14.58% | 16.27% | 17.69% | 17.47% | 6.11% | 15.23% | 14.29% | 14.48% | 22.80% | 22.69% | 22.52% | 19.90% | 14.39% | 10.80% | -8.51% | 7.40% |
| EPS | 10.05 | 10.75 | 10.42 | 9.23 | 7.56 | 6.93 | 6.08 | 5.31 | 5.08 | 1.07 | 1.01 | 0.33 | 0.74 | 0.70 | 0.66 | 0.86 | 0.81 | 0.72 | 0.52 | 0.29 | 0.21 | -0.14 | 0.26 |
| EPS Diluted | 10.05 | 10.71 | 10.35 | 9.19 | 7.52 | 6.90 | 6.06 | 5.30 | 5.07 | 1.06 | 1.01 | 0.33 | 0.74 | 0.69 | 0.65 | 0.86 | 0.80 | 0.71 | 0.51 | 0.28 | 0.21 | -0.14 | 0.26 |
| Weighted Avg Shares Out | 59.80M | 60.22M | 62.27M | 62.97M | 63.94M | 65.50M | 65.75M | 65.76M | 66.39M | 337.56M | 337.88M | 335.53M | 334.63M | 332.50M | 329.66M | 329.71M | 336.66M | 334.35M | 333.02M | 329.93M | 328.16M | 327.48M | 163.11M |
| Weighted Avg Shares Out (Dil) | 59.79M | 60.43M | 62.71M | 63.22M | 64.29M | 65.77M | 65.97M | 65.85M | 66.49M | 338.44M | 338.38M | 336.17M | 335.19M | 335.27M | 333.09M | 331.05M | 340.23M | 338.79M | 336.01M | 333.53M | 330.22M | 328.60M | 163.60M |
Sonova Holding AG (SONVF) Q2 2024 Earnings Call Transcript
Sonova Holding AG (OTCPK:SONVF) Q2 2024 Results Conference Call November 21, 2023 7:00 AM ET Company Participants Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Thomas Bernhardsgrütter - Senior Director, IR Conference Call Participants Daniel Buchta...
Sonova In A Growth And Margin Leverage Gully, But Valuation Makes It Worth Watching
Sonova has experienced a greater than expected hit to market share in the hearing aid market due to the loss of a major retail customer and price-driven market share loss. Sonova's margin performance has likewise come up short, leading to...
HOLX vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?
TMO vs. SONVY: Which Stock Is the Better Value Option?
TMO vs. SONVY: Which Stock Is the Better Value Option?
SONVY or EW: Which Is the Better Value Stock Right Now?
SONVY vs. EW: Which Stock Is the Better Value Option?
SONVY or IDXX: Which Is the Better Value Stock Right Now?
SONVY vs. IDXX: Which Stock Is the Better Value Option?
Sonova Seeing Strong Execution Collide With Macro Uncertainties
Sonova is still logging core growth in the mid-single-digits, but management has acknowledged some pressures from weaker high-margin sales and higher input/fulfillment costs. Macro pressures could lead to consumers trading down or postponing hearing aid purchases in 2023/24, but Sonova's...
Sonova Holding AG (SONVF) Q2 2023 Earnings Call Transcript
Sonova Holding AG (OTCPK:SONVF) Q2 2023 Earnings Conference Call November 14, 2022 7:00 AM ET Company Participants Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Conference Call Participants Daniel Buchta - ZKB Hassan Al-Wakeel - Barclays...
Sonova Holding AG's (SONVF) CEO Arnd Kaldowski on Q4 2022 Results - Earnings Call Transcript
Sonova Holding AG (OTCPK:SONVF) Q4 2022 Earnings Conference Call May 17, 2022 7:00 AM ET Company Participants Thomas Bernhardsgrütter - Director, Investor Relations Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Conference Call Participants Daniel Buchta...
7 Dividend Growth Stocks For 2022
Companies with growing dividends can give you a buffer that prevents you from selling stocks in bad times.
Source: https://incomestatements.info
Category: Stock Reports